Ausper Biopharma Co., Ltd.
Clinical trials sponsored by Ausper Biopharma Co., Ltd., explained in plain language.
-
New shot aims to tame hepatitis b in early human test
Disease control Not yet recruitingThis early-stage study tests a new medicine called AHB-171 in 110 people. First, healthy volunteers receive the injection to check safety. Then, people with chronic hepatitis B get it to see if it helps control the virus. The main goal is to make sure the drug is safe and to meas…
Phase: PHASE1 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New injection tested in patients with liver issues
Knowledge-focused Not yet recruitingThis early-stage study looks at how the body handles a new injection called AHB-137 and whether it is safe. It includes 32 adults with chronic hepatitis B who have either mild to moderate liver problems or normal liver function. The goal is to measure drug levels in the blood and…
Phase: PHASE1 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 04:50 UTC